Clinical trial · people
VIP: peak flow rose 26 l/min in severe asthma, less than salbutamol
Checked against the paper Clinical trialPublished by PepVault
The takeaway
In this small hospital study, VIP given into a vein opened the airways in severe asthma, but less than salbutamol did.
- Kind
- Clinical trial
- Studied in
- People
- Published
- 1986
- Journal
- Peptides
What they tested
The team tested whether VIP given into a vein opens the airways in people with severe asthma, and how it compares with the standard asthma drug salbutamol.
How the study was done
A small clinical trial made of two studies, each in a small group of hospital in-patients who were recovering from a severe asthma attack. VIP was given as an intravenous drip (into a vein) at 6 pmol/kg/min and compared with salbutamol at 5 mcg/min, and VIP was also tested after pretreatment with nebulized ipratropium bromide, another airway drug.

What they found
After 30 minutes of the VIP drip, peak expiratory flow rate (PEFR, how fast a person can blow air out) rose by 26 +/- 9 l/min, a significant change (p less than 0.01). Salbutamol produced a rise of 39 +/- 19 l/min. When patients first had ipratropium bromide, VIP still raised peak flow by 25 l/min (p less than 0.02). The authors concluded that VIP widens the airways in severe asthma but less than standard medicine, and that reflex mechanisms are unlikely to explain its effect.
What it doesn’t show
The groups were small and the effect was measured over a short drip. It tested only intravenous VIP in hospital patients recovering from an attack, so it says nothing about other routes, longer use or milder asthma.
The paper
Morice and Sever Vasoactive intestinal peptide as a bronchodilator in severe asthma. Peptides. 1986.
The compound
More studies on VIP
- VIP (aviptadil): discharge at 7.8 vs 10 days in COVID-19Randomized trial · people · 2025
- VIP fragment VIP10-28 boosted, not blocked, skin vessel wideningClinical trial · people · 2005
- VIP: tear levels rose after laser eye surgery, peaking at 1 weekObservational study · people · 2023
- Every study on VIP
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.